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Abstract
Background:  This study describes the functional interaction between the putative Ca2+ channel
T R P 4  a n d  t h e  c y s t i c  f i b r o s i s  t r a n s m e m b r a n e  c o n d u c t a n c e  r e g u l a t o r ,  C F T R ,  i n  m o u s e  a o r t a
endothelium (MAEC).
Results:  MAEC cells express CFTR transcripts as shown by RT-PCR analysis. Application of a
phosphorylating cocktail activated a Cl- current with characteristics similar to those of CFTR
mediated currents in other cells types (slow activation by cAMP, absence of rectification, block by
glibenclamide). The current is present in trp4 +/+ MAEC, but not in trp4 -/- cells, although the
expression of CFTR seems unchanged in the trp4 deficient cells as judged from RT-PCR analysis.
Conclusions:  It is concluded that TRP4 is necessary for CFTR activation in endothelium, possibly
by providing a scaffold for the formation of functional CFTR channels.
Background
The cystic fibrosis transmembrane conductance regula-
tor (CFTR) is well described as a low-conductance, cyclic
nucleotide-regulated Cl- channel in epithelial cells [1].
Only recently, CFTR has also been detected in vascular
endothelium [2]. Endothelial cells (EC) form an antico-
agulative barrier but also control many other functions,
such as regulation of the vascular tone by secretion of va-
soactive compounds such as bradykinin, and autocoids,
such as nitric oxide and prostacyclin [3]. These functions
are modulated by a diversity of ion channels among
which Cl- channels [4,5]. Endothelial Cl- channels, the
volume-regulated anion channel, VRAC, and Ca2+ acti-
vated Cl- channels, CaCC, have been shown to modulate
EC electrogenesis, are possible mechano-sensors, serve
as permeation pathways for amino acids and organic os-
molytes and may be involved in regulation of the driving
force for Ca2+ entry [for a review, see 6]. This list of Cl-
channels has been extended with CFTR, which is func-
tional in human umbilical vein endothelium and in hu-
man lung microvascular endothelial cells [1], but not in
bovine pulmonary artery endothelial cells [6]. As we
show in this work, it is also functional in mouse aorta en-
dothelial cells.
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MAEC express different types of putative ion channel
transcripts which are encoded by genes of the trp family,
trp1, 2, 3, 4, and 6 [7,8]. TRP4 forms part of a store oper-
ated Ca2+ entry channel which is involved in the control
of NO-dependent relaxation of the mouse aorta [8]. In
addition, TRP4 has been shown to interact via a VTTRL
motif in its C-terminal region with the first PDZ domain
of the regulatory factor of the Na+- H+exchanger
NHERF, which also interacts with PLCβ  [9]. The two
PDZ domain protein NHERF associates also with the ac-
tin cytoskeleton via members of the ezrin/radixin/moes-
in family [10,11]. It is also well established that the C
terminus of CFTR constitutes a PDZ-interacting domain
(QDTRL for the last five C-terminal amino acids) that is
required for CFTR polarization to the apical plasma
membrane and interaction with the PDZ domain-con-
taining protein NHERF [12]. Thus, both TRP4 and CFTR
may bind to similar PDZ-domain proteins.
We have studied the functional expression of CFTR in
both trp4 wild type and in trp4 deficient MAEC cells. We
show here that CFTR is present in both cell types, but is
not functional in trp4 deficient endothelial cells. These
data may hint to a more general function of trp4 as regu-
lator of other ion channels and to a novel regulatory
mechanism for CFTR.
Results
Expression of CFTR in mouse aorta endothelium
We have been unable to detect CFTR in bovine pulmo-
nary endothelial cells [6], but its expression has recently
been described in endothelium [1]. We have therefore as-
sessed the expression of CFTR in mouse aorta EC
(MAEC) by means of two sets of primers, the one detect-
ing exon 5 through exon 9 of CFTR transcripts, and the
other one detecting exons 23 and 24 of CFTR transcripts
(figure 1A, B). The data show that CFTR is expressed in
both wild-type and trp4 deficient MAEC cells, and are
consistent with the recent detection of CFTR expression
in human umbilical vein endothelium and human lung
microvascular endothelial cells.
Figure 1
RT-PCR showing the expression of CFTR in mouse aorta endothelial cells   A) cDNA from murine TRP4 +/+ and
TRP4 -/- MAEC (lanes 1 and 2), human umbilical vein cells (HUVEC, lane 3) and human nasal epithelium cells (+, for a positive
control) were amplified using primers P.CFTR-3249.5 and P.CFTR-3428.3, generating a 180 base pair fragment encoding partial
sequences of exons 17a and 17b. Lane 5 is a negative control. B) cDNA from murine TRP4 +/+ and TRP4 -/- MAEC (lanes 1
and 2), from three different preparations of cDNA from HUVEC cells (lanes 3, 5 and 6) and human nasal epithelial cDNA as a
positive control (lanes 4 and 7) were amplified using primers PF.CFTR-661.5 and P.CFTR-1360.3, generating a 700 bp fragment
harboring exons 5 through 9. Lane 8 is the negative control of amplification.BMC Physiology (2001) 1:3 http://www.biomedcentral.com/1472-6793/1/3
Functional characterization of CFTR in MAEC
Subsequently, we have investigated the functional ex-
pression of CFTR in wild type MAEC. Application of the
phosphorylating cocktail, containing10 µ M forskolin and
100 µ M IBMX, activated in these cells a current without
any apparent rectification and voltage-independent ki-
netics, which reversed at -26 ±  6 mV (n = 6), i.e. close to
the Cl-equilibrium potential, ECl (figure 2A). Its pheno-
type was completely different from that of Cl- currents
activated by loading the cells with Ca2+ (figure 2B),
which are outwardly rectifying, slowly activate at positive
potentials and inactivate at potentials negative to ECl
[13,14]. Challenging the MAEC with a 25 % hypotonic ex-
tracellular solution activated another type of Cl- current
that inactivates at positive potentials and shows a less
pronounced outward rectification (figure 2C). The latter
currents have been described in detail in other EC as
VRAC, volume-regulated anion currents [6,15,16]. The
cAMP-activated current reached a stationary value ap-
proximately 2 minutes after application of the phospho-
rylating cocktail (figure 3A), and disappeared after wash-
out of the phosphorylation cocktail. The cAMP-activated
current was observed in 16 out of 22 cells, but its density
was rather small (4.9 ±  1.1 pA/pF at +50 mV, obtained
from voltage ramps, n = 16) compared to that of the other
Cl- currents. It was activated without any change in cell
volume or elevation of intracellular Ca2+. Glibenclamide
(50 µ M) blocked the cAMP-activated current by 62 ±  4 %
(n = 6) (figure 3D). Obviously, the profile of this current
is similar to that of CFTR currents in other tissues, i.e.
slow activation, linear I-V curve, time-independent ki-
netics and inhibition by glibenclamide, indicating that
CFTR channels are also functionally expressed in MAEC,
and coexist with at least two other types of Cl-channels.
Down-regulation of CFTR currents in trp4-deficient MAEC
The phosphorylating cocktail failed to activate a similar
current in trp4-deficient MAEC. Figure 4 shows an ex-
ample for stimulating wild-type and trp4- deficient
MAEC. On the other hand, the CaCC current activated by
loading MAEC with 1 µ M [Ca2+]i was not significantly
different from that in wild type MAEC, i.e. 16 ±  4 pA/pF
in WT(n = 11) compared to 24 ±  6 pA/pF (n = 8) in trp4
-/- cells at +100 mV. Also VRAC was not significantly dif-
ferent in both cell types (peak currents at +100 mV: 58 ±
8 pA/pF, n = 7, in WT cells; 55 ±  11 pA/pF, n = 6 in trp4
-/- MAEC).
Discussion
We show that mouse aorta endothelial cells express func-
tional CFTR channels, and that their activation is defec-
tive in mouse aorta endothelium of trp4-deficient mice,
although these cells still expressed the CFTR transcripts.
CFTR expression has already been demonstrated in hu-
man umbilical vein (HUVEC) and lung microvascular
endothelial cells (HLMVEC) [1], but was not detectable
in bovine pulmonary artery endothelial cells [6]. We
show here that CFTR is also expressed as a functional
channel in mouse aorta endothelial cells. It has been sug-
gested that the endothelial CFTR has 100% identity with
the corresponding epithelial cDNA from exon 3 to exon
6, including exon 5 which is absent in cardiac CFTR [1].
CFTR is also present in corneal, non-vascular endotheli-
um [17]. In MAEC cells, the first arterial cell type de-
scribed to express CFTR, cAMP activated Cl- currents are
smaller than Ca2+ activated and volume-regulated Cl-
currents in the same cell type. Activation of CFTR in en-
dothelial cells could be of functional interest in transen-
dothelial transport, in pH regulation because of the
CFTR permeability for bicarbonate, and intriguingly also
as part of the NO signaling cascade because of their sen-
sitivity to cGMP, which might be elevated during en-
dothelial NO production.
Besides its role as a Cl- channel, CFTR also regulates the
activity of various ion channels and transporters, mainly
via direct protein-protein interactions [18,19]. Some of
these interactions might be mediated by the association
of CFTR via its C-terminal PDZ-binding motif (D-T-R-L)
with the PDZ-binding domains of other proteins, such as
NHERF [11,12,20,21]. CFTR also functions as regulator
of ATP release [22,23], which might be important for EC
function because the released ATP could in turn bind to
endothelial P2Y2 and P2X4 receptors [for a review, see
6].
The finding that CFTR, although detectable in RT-PCR,
cannot be activated in trp4-defiecint mouse aorta en-
dothelium might be of a special interest, since it shows
that the functional activity of CFTR may be connected to
the expression of trp4, a member of the trp-family that is
involved in capacitative Ca2+ (CCE). CCE, mediated via
store-operated channels (SOC), may affect CFTR activity
indirectly via modulation of adenylyl or guanyl cyclases.
It has indeed been shown that block of CCE by micromo-
lar concentrations of La3+ ions inhibits cyclic AMP syn-
thesis [24,25]. In endothelial cells, CCE is the principle
stimulus for sustained activation of eNOS [26], and the
concomitant elevation of the cGMP concentration may in
turn activate CFTR [27,28].
Alternatively, TRP4 may interact more directly with
CFTR by forming a signaling complex via binding of their
PDZ-binding motifs to PDZ-domain proteins. The Na+/
H+ exchanger regulatory factor, NHERF, has been iden-
tified as a protein that binds both TRP4 and CFTR [10].
Also light activated TRP channels in the Drosophila pho-
toreceptor cluster with several other signaling proteinsBMC Physiology (2001) 1:3 http://www.biomedcentral.com/1472-6793/1/3
by associating with the PDZ-domain protein INAD. It is
therefore not unlikely that TRP4 and CFTR associate in
MAEC via similar PDZ-domain proteins, such as NHERF
or the human INAD-Like (hINAD-L) protein [29].
Conclusions
This is the first report describing a functional interaction
between a member of the TRP family and CFTR. It is
therefore tempting to speculate that TRPs might be ei-
ther regulators of CFTR or targets of CFTR regulating
proteins.
Figure 2
At least three different Cl- channels exist in MAEC  A. Current traces in a non-stimulated MAEC cell (upper traces) and
in the same cell stimulated with the phosphorylation cocktail (lower traces) in response to voltage steps from +80 to -80 mV
(decrement = 40 mV, VH = 0 mV). The bottom panel shows the corresponding I-V curves from the current amplitudes
recorded at the end of each voltage step (open circles for the resting cell and open triangles for the stimulated cell). Note t he
voltage-independent kinetics of the current, the lack of rectification and the reversal potential close to ECl B. Current traces in
an MAEC cell immediately after breaking into the cell and before it is loaded with Ca2+ (upper traces) and after equilibration
with pipette Ca2+ (1 µ M). Voltage steps form -100 to +100 mV (increment +20 mV), VH is -20 mV. Note the slow activation at
positive potentials, and the inactivation at negative potentials, which are typical for CaCC currents. The corresponding I-V
curves in the bottom panel illustrate the strong outward rectification of the CaCC current. C. Current traces from an MAEC
cell before and during cell swelling induced by challenging the cell with a 25 % hypotonic solution. Same step protocol as in B.
Note the inactivation of the current at positive potentials, which is a feature of volume-regulated anion channels (VRAC). The
corresponding I-V curves at the bottom illustrate the weak outward rectification of the VRAC currents.BMC Physiology (2001) 1:3 http://www.biomedcentral.com/1472-6793/1/3
Materials and Methods
Cell isolation
Gene targeting for the construction of the trp4 deficient
mouse has been described in detail elsewhere[8]. In
short, part of the exon encoding transmembrane domain
4 and 5 and part of the linker between S5 and S6 was re-
placed by the neomycin-resistance gene and the deletion
of the trp4 gene and lack of expression was confirmed
[8].
The "primary explant technique" was used to study
freshly isolated endothelial cells from mouse aorta of
trp4 +/+ (wild type) and trp4 -/- mice [30]. In short, the
aorta was removed form anesthetized and heparinized
mice. Small pieces of the aorta were placed with their in-
timal side on matrigel-coated six well plates containing a
very small volume of growth medium (mix for 100 ml: 80
ml DMEM (GIBCO BRL 41965) with in addition 10 ml
FCS, 7.5 mg ECGF, 200 µ l heparin (10 U/ml final), 2 ml
penicillin/streptomycin (100 U/ml final, GIBCO BRL
15070), 1 ml L-glutamine (100x, GIBCO BRL 25030-
024), and 1 ml Minimal Essential Amino acids so that the
aortic pieces adhere to the substratum. Matrigel-coated
plates contained TGFβ , FGF, and tPA. Additional en-
dothelial cell growth factors were added (75 µ g/ml,
ECGS, endothelial cell growth factor supplement, E2759,
Sigma). Addition of heparin induced an antiproliferative
effect on smooth muscle cells and fibroblasts. After ap-
proximately 6 days, we removed the aortic pieces and let
the endothelial cells that have migrated from the aortic
segments grow to confluence. In this state, explanted en-
dothelial cells can be studied on the matrigel support.
For further investigations, cells were passaged by using
dispase (Becton Dickinson, Two Oak Park, Bedford, MA,
USA). Thereafter, growth medium was added to stop the
Figure 3
cAMP activated Cl- currents in MAEC  A. Slow activation of the CFTR currents. Currents values were obtained form lin-
ear voltage ramps and were measured at +50 mV (holding potential, VH = 0 mV). B. Instantaneous current-voltage relation-
ships measured from voltage ramps at the times indicated by solid circles (a and b) in panel A. C. Difference current, b-a, from
the current measured after and before stimulation with the cAMP elevating cocktail. From such protocols current density was
measured for the wild type and the trp4-deficient MAEC (see figure 4). D. Block of the cAMP activated current by 50 µ M glib-
enclamide (measured from voltage ramps at +50 mV, V H = 0 mV)BMC Physiology (2001) 1:3 http://www.biomedcentral.com/1472-6793/1/3
Figure 4
Failure of CFTR activation in trp4 deficient MAEC  A. Current traces from a wild type MAEC obtained from steps pro-
tocols (voltage steps from +80 to -80 mV, decrement 40 mV, holding potential was VH = 0 mV). B. Same protocol as in panel
A, but after application of the phosphorylating cocktail C. Same protocol as in A, but for a trp4 deficient cell. D. Same protocol
as in C for the trp4 -/- cell after stimulation with the phosphorylating cocktail. E. Pooled current densities at +50 mV (obtained
from voltage ramps) in wild type and trp4 deficient MAEC under resting conditions (cont) and after stimulation with the phos-
phorylating cocktail (cAMP). Note the lack of current activation by the phosphorylating cocktail in the trp4 deficient MAEC.
Amplitude of the cAMP activated current in wild type (+/+) and trp4 deficient (-/-) endothelial cells, i.e. the difference between
the current amplitudes in stimulated and unstimulated cells in panel E.BMC Physiology (2001) 1:3 http://www.biomedcentral.com/1472-6793/1/3
dispase activity by dilution. Cells were then harvested,
centrifuged and resuspended with DMEM.
Reverse Transcriptase Polymerase Chain Reaction (RT-
PCR)
Total RNA was isolated using TRIzol Reagent (Gibco
BRL Life Technologies), according to the protocol pro-
vided by the manufacturer. After priming with oligo-dT
oligonucleotides, cDNA was synthesized with MLV re-
verse-transcriptase (Life Technologies) according to the
recommendations of the supplier. The cDNA was used as
template in a polymerase chain reaction (PCR), using 5
µ l of a cDNA synthesis reaction in a 50 µ l amplification
reaction. The amplification was performed in a DNA
Thermal Cycler (Perkin Elmer). The temperature cycling
conditions were: denaturation for 1 minute at 95° C, an-
nealing for 1 minute at a temperature that is specific for
each pair of primers (55° C for the primer couple P.CFTR-
661.5 (5'-AAG TAT TGG ACA ACT TGT TAG TC-3' corre-
sponding to nucleotides 661 to 683 of mouse CFTR cD-
NA, Accession number M69298) and P.CFTR-1360.3
(5'-TAA TTC CCC AAA TCC CTC CTC-3' 3' corresponding
to nucleotides 1360 to 1340 of mouse CFTR cDNA, Ac-
cession number M69298), which amplify a 700 base pair
fragment encompassing exon 5 (partial) through exon 9
(partial); and 60° C for the primer couple P.CFTR-3249.5
(5'-TGG AAT CTG AAG GCA GGA GTC-3' corresponding
to nucleotides 3249 to 3269 of mouse CFTR cDNA, Ac-
cession number M69298) and P.CFTR-3428.3 (5'-TTC
TCA TTT GGA ACC AGC GCA-3' corresponding to nucle-
otides 3428 to 3408 of mouse CFTR cDNA, Accession
number M69298), which amplify a 180 base pair frag-
ment excompassing exons 17a and 17b partially), exten-
sion at 72° C for 1 minute for fragments smaller than 1 kb
for a total of 35-45 cycles, with a final extension step of
10 minutes to fully extend any remaining single stranded
DNA. The first denaturation step was done for 6 minutes
at 95° C.
Solutions and electrophysiology
For measurement of CFTR currents, we started the ex-
periment by using a bath solution that contained (in
mM): 150 NaCl, 6 KCl, 1 MgCl2, 1.5 CaCl2, 10 glucose, 10
HEPES, titrated with NaOH to pH 7.4. The Cl- equilibri-
um potential, ECl, is -36 mV. We then switched to a solu-
tion in which KCl had been substituted by CsCl. CFTR-
channels were activated by a cocktail containing 100 µ M
IBMX (3-isobutyl-1-methylxanthine) and 10 µ M forsko-
lin (both from Sigma-Aldrich Chemie) dissolved in the
bath solution. The pipette solution contained (in mM):
40 CsCl, 100 Cs-aspartate, 1 MgCl2, 0.1 EGTA, 4
Na2ATP, 10 HEPES, pH 7.2 with CsOH. Experiments
were done at room temperature, ∼  22° C.
Ca2+ activated Cl- currents were measured as described
earlier [13,14]. The bath solution contained (mM): 150
NMDG-chloride, 1 MgCl2, 1.5 CaCl2, 10 glucose, 50 man-
nitol, 50 nM charybdotoxin, 10 HEPES, titrated with
NaOH to pH 7.4. Mannitol was used to suppress co-acti-
vation of volume-regulated anion channels (VRAC).
Charybdotoxin (Sigma) was added to inhibit the big-con-
ductance Ca2+ activated K+ channels, BKCa which is also
present in MAEC cells [30]. The pipette solution con-
tained (mM): 100 Cs-aspartate, 40 CsCl, 1 MgCl2, 4
Na2ATP, 1 µ M Ca2+ buffered with 10 mM EGTA (CaBuf
program, G. Droogmans, Leuven), 10 Hepes, pH 7.4 with
CsOH.
Activation of VRAC has also been described in detail
[16,30]. In short, at the beginning of the patch-clamp re-
cording, the Krebs solution was replaced by an isotonic
Cs+ solution to suppress K+ currents, containing (in
mM): 105 NaCl, 6 CsCl, 1 MgCl2, 1.5 CaCl2, 10 glucose, 90
mannitol, 10 HEPES, pH 7.4 with NaOH (320 ±  5
mOsm). Hypotonic solutions were obtained by omitting
90 mM mannitol from this solution (240 ±  5 mOsm). A
pipette solution was used containing (in mM): 40 CsCl,
100 Cs-aspartate, 1 MgCl2, 1.93 CaCl2, 5 EGTA, 4
Na2ATP, 10 HEPES, pH 7.2 with CsOH (290 mOsm).
This solution is slightly hypotonic compared to the
Krebs' solution to avoid spontaneous activation of vol-
ume-sensitive Cl- currents. The concentration of free
Ca2+ in this solution was buffered at 100 nM, which is be-
low the threshold for activation of Ca2+ activated K+ and
Cl- currents and also prevents activation of non-selective
cation channels.
MAEC cells were patch clamped as described previously
[8,30]. Currents were monitored with an EPC-7 patch
clamp amplifier (List Electronic, Germany). Patch elec-
trodes had a resistance between 3 and 5 MΩ . An Ag-AgCl
wire was used as reference electrode. VRAC and CaCC
whole-cell membrane currents were measured in rup-
tured patches, sampled at 2 ms intervals (1024 points per
record, filtered at 200 Hz), unless otherwise mentioned.
All experiments were performed at room temperature
(20-23° C).
The I-V curve of CFTR currents was derived from 400 ms
linear voltage ramps from -100 mV to +100 mV or from
400 ms voltage steps to potentials ranging from +80 to -
80 mV (in decrements of 40 mV) applied from a holding
potential of 0 mV [31,32]. Currents were sampled at 1 ms
intervals (512 points) and filtered at 5 kHz.
Data analysis
Electrophysiological data were analyzed using the Wi-
nASCD software (G. Droogmans, Leuven). Pooled data
are given as mean ±  S.E.M. from n cells. Significance wasBMC Physiology (2001) 1:3 http://www.biomedcentral.com/1472-6793/1/3
tested using Student's paired t test (P < 0.05 are marked
with an asterisk).
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